JSP targets revenue growth in 2026 as planned, advancing three core strategies

Earnings
โดย HoonVision·Read original
Summary · why it matters

JSP is confident that revenue in 2026 will grow as targeted, despite first-half profit being pressured by volatile oil and packaging costs. Group CEO Dr. Sittichai Daengprasert revealed that the company is driving its business through three core strategies: the OEM business, which continues to grow thanks to rising demand for health products; the company's own brand under the name Supap Osot, which is seeing clear growth especially through online channels; and mergers and acquisitions to strengthen capabilities, with existing subsidiaries continuing to grow and additional opportunities under consideration.

Impact on stocks 1

Biotech & Genomic Medicine · 1 stocks